LatinoWire

December 13, 2024 02:13 PM Eastern Time

BrightPath Bio和Cellistic宣布就iPSC来源的BCMA CAR-iNKT细胞1期临床试验开展工艺开发和生产合作

Opens in new window

Download

Full Size JPEG, 1476x542, 211.5 KB
Small JPEG, 480x176, 39.3 KB
Preview JPEG, 144x53, 6.5 KB
Thumbnail JPEG, 120x44, 4.7 KB

Smart Multimedia Gallery

http://www.businesswire.com/multimedia/latinowire/20241213090989/zh-CN/5761630/

Share

Email

All News | News with Multimedia > Press Release: BrightPath Bio和Cellistic宣布就iPSC来源的BCMA CAR-iNKT...

Get Business Wire News on Your Website

Terms of Use | © 2024 Business Wire